JAMISON PRIVATE WEALTH MANAGEMENT, INC.

Position in NVS — Novartis AG

CIK 2006637 MILTON, GA

Position in NVS

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$2,646,687

+$69,642 QoQ

Shares Held

16,888

+0.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.29%

of 13F equity value

Holder Rank

#374

of 1,603 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

JAMISON PRIVATE WEALTH MANAGEMENT, INC. holds $91,657,805 across 12 Drug Manufacturers - General names. NVS ranks #7 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	20,014	$24,005,394
2	JNJ	Johnson & Johnson	88,830	$22,560,155
3	ABBV	AbbVie Inc.	60,804	$15,300,718
4	AMGN	Amgen Inc	28,719	$10,399,724
5	MRK	Merck & Co., Inc.	38,278	$4,918,723
6	GILD	Gilead Sciences, Inc.	32,855	$4,150,900
7	NVS	Novartis AG This page	16,888	$2,646,687
8	PFE	Pfizer Inc	106,195	$2,557,175

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,646,687	16,888	+0.1%	Shares	Sole	2026-07-16
2026-03-31	$2,577,045	16,871	0.0%	Shares	Sole	2026-04-27
2025-12-31	$2,326,004	16,871	-2.1%	Shares	Sole	2026-01-15
2025-09-30	$2,209,190	17,227	-1.9%	Shares	Sole	2025-10-14
2025-06-30	$2,125,903	17,568	-0.6%	Shares	Sole	2025-07-22
2025-03-31	$1,970,743	17,678	-3.9%	Shares	Sole	2025-04-22
2024-12-31	$1,790,309	18,398	0.0%	Shares	Sole	2025-01-21
2024-09-30	$2,116,137	18,398	0.0%	Shares	Sole	2024-10-15
2024-06-30	$1,958,651	18,398	-1.2%	Shares	Sole	2024-07-11
2024-03-31	$1,801,499	18,624	-0.3%	Shares	Sole	2024-04-26
2023-12-31	$1,886,321	18,682	+0.3%	Shares	Sole	2024-01-17
2023-09-30	$1,898,059	18,634	—	Shares	Sole	2024-01-05
No filing history on record for this holder in this stock.